Clinical Trials Browser

Phase 2 × Sarcoma × Therapeutics × Clear all

NCT00357396 2015-11-25

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Phase 2 Completed

10 enrolled 7 charts

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral